A double-blind comparison of naproxen and indomethacin in rheumatoid arthritis.
D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D006261:Headache / Q000139:chemically induced; D006801:Humans; D007213:Indomethacin / Q000009:adverse effects / Q000627:therapeutic use*; D008738:Methyl Ethers / Q000009:adverse effects / Q000627:therapeutic use; D008875:Middle Aged; D009281:Naphthalenes / Q000009:adverse effects / Q000627:therapeutic use; D009325:Nausea / Q000139:chemically induced; D011422:Propionates / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors
D000893:Anti-Inflammatory Agents; D008738:Methyl Ethers; D009281:Naphthalenes; D011422:Propionates; D007213:Indomethacin